It is with great pleasure we invite you to participate in the 14th International Conference on Osteogenesis Imperfecta in Sheffield, UK, from 5-8 September 2020.
The international osteogenesis imperfecta conference brings together scientists and clinicians from a wide range of disciplines, presenting updates on developments in current scientific research, medical and surgical treatment options as well as discussions around topics such as rehabilitation, quality of life, pain, mental health and service development.
The scientific programme will highlight state-of-the-art clinical practices, recent advances as well as new data and perspectives, in a format designed to encourage interaction and collaboration between all stakeholders. We aim to cover a wide range of topics, from state of the art research to the broad spectrum of clinical situations that physicians might encounter.
Our goal is that all members of the OI-community will benefit from taking part in the event - including clinical and scientific researchers, clinicians, therapists and other health care professionals as well as representatives from patient organisations.
The multidisciplinary nature of the conference provides an opportunity to talk to specialists from many different fields including geneticists, internists, endocrinologists, orthopaedic surgeons, dentists, radiologists, paediatricians, physiotherapists, nurses as well as patient and industry representatives.
Sheffield is England’s 5th largest city, and with its two universities has been voted the UK’s most popular student destination. It has a vibrant and diverse social scene, and at the same time is one of the UK’s greenest cities, with one third of the city lying within the Peak District National Park. Transport links are good and there is a choice of international airports within an hour of the city.
The meeting takes place on the University of Sheffield campus, meaning that accommodation and meeting facilities are easily accessible and a short walk apart. It also means that we can offer very low accommodation rates, starting at £45 per night for bed and breakfast.
Please submit your abstracts on any relevant topic and we hope that you will be able to join us for an exciting meeting with constructive discussions about state of the art clinical and basic science related to osteogenesis imperfecta.
Hope to see you in Sheffield in September 2020!
OI2020 Meeting Chair
Joan Marini – Chair (Bethesda, USA)
Franco Antoniazzi (Verona, Italy)
Darko Anticevic (Zagreb, Croatia)
Nick Bishop (Sheffield, UK)
Peter Byers (Seattle, USA)
Raymond Dalgleish (Leicester, UK)
Anne de Paepe (Ghent, Belgium)
François Fassier (Montreal, Canada)
Antonella Forlino (Pavia, Italy)
Francis Glorieux (Montreal, Canada)
Gerard Pals (Amsterdam, the Netherlands)
Cathleen Raggio (New York, USA)
Marianne Rohrbach (Zurich, Switzerland)
Oliver Semler (Cologne, Germany)
Lena Lande Wekre (Oslo, Norway)
The international conference on OI takes place every third year, usually switching between a venue in the US and Europe every second time. The conference provides an international forum for the presentation and discussion of current basic and clinical science in the field of osteogenesis imperfecta in children, adolescents and adults.
The conference was initiated by an international group of independent clinicians and researchers interested in osteogenesis imperfecta. Thirteen conferences have been organised successfully as a collaboration between the scientific committee and local organizers; the last being held in Oslo in 2017.
The most recent meetings have been held as follows:
2017 Oslo, Norway
2014 Wilmington, Delaware, USA
2011 Dubrovnik, Croatia
2008 Ghent, Belgium
2005 Annapolis, Maryland, USA
2002 Annecy, France
Around 200-250 attendees are expected at the 2020 meeting and are expected to include:
At the conclusion of the programme:
The Conference will bring together scientists and clinicians from a wide range of disciplines, presenting cutting edge news from basic science, current research as well as medical and surgical treatment of OI.
The scientific programme will strive to highlight state-of-the-art clinical practices, recent advances as well as new data and perspectives, in a format designed to encourage interaction and collaboration between all stakeholders. We aim to cover a wide range of topics, from state of the art research to the broad spectrum of clinical situations that physicians might encounter.
Our goal is that all members of the OI-community will benefit from taking part in the event – including clinical and scientific researchers, clinicians, therapists, other health care professionals as well as representatives from patient organisations.
There are opportunities for presentations (oral communications and posters) based on submitted abstracts.
The abstract deadline is Friday 1 May 2020.
New Investigator Awards will be offered to abstract authors according to mean score achieved during the blind reviewing process. Awards winners will be notified by email by 27 May 2020.
To be eligible for a New Investigator Award an author must be:
1. First and presenting author
2. Must be in training or within 3 years of attaining PhD or MD or equivalent and/or aged under 35
Additional New Investigator Awards will be provided by ECTS. Members of ECTS who fit the above criteria will be eligible to apply for these ECTS awards.
To apply please tick the box on the abstract form and send a confirmation of eligibility as instructed on the form.
You are cordially invited to join the list of supporters of the 14th International Conference on Osteogenesis Imperfecta (OI2020).
OI2020 will offer a high quality scientific programme of interest to both clinical and basic scientists. We’re expecting between 200 and 250 delegates from all around the world to attend, including many key opinion leaders in the field.
The conference is quite unique in attracting professionals and patient representatives alike, which offers a broad exposure of your products. Leading professionals will influence colleagues worldwide in their choice of therapeutic modalities, and patient organisations will bring news of your product to members. Despite a relatively low number of delegates, which in many ways makes the conference more enjoyable for everybody attending, the exposure of your products will reach far beyond the visitors at the conference.
The multidisciplinary nature of the conference provides an opportunity to talk to specialists from many different fields including geneticists, internists, endocrinologists, radiologists, orthopaedics, paediatricians, dentists, physiotherapists, nurses and others working with osteogenesis imperfecta and other metabolic and bone related disorders as well as other rare disorders.
We hope that you will be able to join us for an exciting meeting with constructive discussions about state of the art clinical and basic science related to osteogenesis imperfecta. Please contact us to discuss sponsorship and exhibition options.
We are delighted to be hosting the meeting in the vibrant city of Sheffield, South Yorkshire. With its two universities, it has a world-class reputation for teaching and research, and the city is one of the UK’s greenest, and also one of the most lively. Although England’s 5th largest city, it is compact and easy to get around with plenty of good accommodation at affordable prices at walking distance from the conference venue and social events. A trip to Sheffield would not be complete without a trip to the nearby Peak District National Park, Britain’s first national park, established in 1951, a must for any walkers, cyclists, cavers, climbers or simply anyone who enjoys exploring the English countryside. From wild moorlands, through limestone dales, bustling market towns and pretty villages, the Peak District is an area of amazing variety and contrast. If you have time we would highly recommend a visit at the end or beginning of your stay.
The meeting will take place at The Edge, a meeting venue on the University of Sheffield Endcliffe Village student campus. Accommodation in different categories is available on the same campus.
Address: The Edge, 34 Endcliffe Crescent, Sheffield S10 3ED
|Registration fee||Full rate||
Earlybird, until 23:59 Thursday 4 June 2020 £480
Friday 5 June onwards £550
|Registration fee||Discounted rate*||
Earlybird, until 23:59 Thursday 4 June 2020 £300
Friday 5 June onwards £370
|Bed and breakfast||Jonas Hall||£65 per night|
|Bed and breakfast||Endcliffe Village Student Halls||£45 per night|
|Dinner Saturday 5 September
|Dinner Monday 7 September
To register at the discounted rate you must be one of the following:
- an undergraduate
- a current MD/PhD student
- within 5 years of obtaining an MD/PhD
- an Allied Health Professional
- a registered patient group representative*
- based in a low or developing income country (see list)
*The meeting programme is designed for healthcare professionals and researchers. Pharma industry regulations do not allow open invitations to members of the public to attend. However, patient organisation representatives are encouraged to register to attend the meeting provided they meet the following criteria (evidence in the form of a letter on the organisation’s letterhead is required):
- They represent a formally registered international organisation with elections (or national with some international activities) and
- They are a member of the management group or are officially nominated by the management group or are a paid member of staff
Terms and Conditions
Late registration surcharge
Delegates registering at the early bird rate must ensure that their fees are paid by the early bird deadline (4 June) otherwise the standard fee will apply.
The deadline for pre-conference registrations is Wednesday 26 August 2020. Registrations made after this date may not be processed prior to the conference.
Accommodation bookings and/or changes cannot be made after Wednesday 26 August 2020.
Cancellations will be accepted in writing until 23:59 on Thursday 4 June, until which time a 70% refund will be given. There will be no refunds for cancellations received after this date, although substitutions can be made until Wednesday 26 August 2020.
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The authorisation request must be submitted within 70 days before the start date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
Alijet & Fargo International Srl
Via P. Maroncelli 44-46-48-50
There are three airports within easy reach of Sheffield (approximately 1 hour travelling time), Manchester, Leeds Bradford and East Midlands.
London Heathrow and London Gatwick are also accessible by train with just one change in London.
The journey from London takes approximately 2 hours, while Manchester, Leeds and Birmingham are around 1 hour.
Please see here for information about discounted rail travel for conference delegates travelling to Sheffield with East Midlands Trains.
Organised by ICCBH - International Conference on Children's Bone Health - in association with the European Calcified Tissue Society